Trial of Solanezumab in Preclinical Alzheimer's Disease. Sperling RA, Donohue MC, Raman R, Rafii MS, et al. N Engl J Med 2023 Jul 17. doi: 10.1056/NEJMoa2305032.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sperling RA, Donohue MC, Raman R, Rafii MS, et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med 2023 Jul 17. doi: 10.1056/NEJMoa2305032.
PMID: 37458272